Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Legislation and drug trials.

Walsh D, Drumm B.

Arch Dis Child. 1997 Apr;76(4):296-7. No abstract available.

2.

Requirements to be fulfilled before instituting clinical trials on new drugs.

Griffin JP.

Proc R Soc Med. 1974 Jun;67(7):581-4. No abstract available.

3.

A survey of products licensed in the United Kingdom from 1971-1981.

Griffin JP, Diggle GE.

Br J Clin Pharmacol. 1981 Oct;12(4):453-63. No abstract available.

4.

Clinical study reports are not commercially confidential, says UK government.

Kmietowicz Z.

BMJ. 2013 Nov 19;347:f6942. doi: 10.1136/bmj.f6942. No abstract available.

PMID:
24252568
5.

Evidence based medicine and ethics.

Hope T.

J Med Ethics. 1995 Oct;21(5):259-60. No abstract available.

6.

The impact of clinical trials legislation on clinical pharmacology: problems and solutions.

Brown MJ.

Br J Clin Pharmacol. 2009 May;67(5):487-93. doi: 10.1111/j.1365-2125.2009.03379.x. Epub 2009 Feb 2. No abstract available.

7.

Ethics and drugs.

Goldberg A.

Ir J Med Sci. 1990 Aug;159(8):242-3. No abstract available.

PMID:
2076946
8.

Replication of clinical trials.

Silverman WA.

Lancet. 1986 Aug 9;2(8502):348. No abstract available.

PMID:
2874359
9.

Post-marketing surveillance of licensed medicinal and other products.

Griffin JP.

Health Bull (Edinb). 1981 Nov;39(6):356-66. No abstract available.

PMID:
7035401
10.

Impediments to clinical research in the United States.

Kramer JM, Smith PB, Califf RM.

Clin Pharmacol Ther. 2012 Mar;91(3):535-41. doi: 10.1038/clpt.2011.341. Epub 2012 Feb 8.

PMID:
22318614
11.

Drug-abuse reporting systems.

Rootman I, Hughes PH.

WHO Offset Publ. 1980;(55):1-98. No abstract available.

PMID:
7324569
12.

Letter: Ethics and halothane.

Payne JP.

Br Med J. 1974 Oct 12;4(5936):101. No abstract available.

13.

The medical ethics of clinical therapeutic trials.

de Wet BS.

S Afr Med J. 1973 Jan 6;47(1):18-21. No abstract available.

PMID:
4686243
14.

Doctors, drugs and drug abuse.

Edwards JG.

Practitioner. 1974 Jun;212(1272):815-22. No abstract available.

PMID:
4423189
15.

Heroin maintenance for heroin addicts: issues and evidence.

Koran LM.

N Engl J Med. 1973 Mar 29;288(13):654-60. Review. No abstract available.

PMID:
4568989
16.

Regulations and procedures for new drug evaluation and approval in China.

Yin H.

Hum Gene Ther. 2006 Oct;17(10):970-4. Review. No abstract available.

PMID:
16958562
17.

[Ethical problems in clinical research at pediatric departments].

Sovik O.

Tidsskr Nor Laegeforen. 1975 Aug 10;95(22):1197-200. Norwegian. No abstract available.

PMID:
1099716
18.

India's top drug regulator.

Jayaraman K.

Nat Med. 2014 Aug;20(8):802-5. doi: 10.1038/nm0814-802. No abstract available.

PMID:
25100517
19.

[Clinical drug trials. Part 2. Legal regulations, (EG-) guidelines, ethics commission].

Gleiter CH, Bieck PR.

Fortschr Med. 1991 Apr 20;109(12):267-70. German. No abstract available.

PMID:
1855758
20.

Women, drug control and the law.

Connors J.

Bull Narc. 1990;42(1):41-7.

PMID:
2095935

Supplemental Content

Support Center